Evidence map›Paper›PMID 41498981›Full record

ArticleMikrochimica acta2026

Thermo-alkaline-activated ZrFe-MOF interface for ultrasensitive electrochemical MiRNA biosensing.

Ruimiao Chang, Shumian Liu, Jingjing Wang, Huichun Wang, Shuai Jia, Yuting Ye, Xinying Qu, Yong Li, Ji Zheng, Xiaoxing Fang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruimiao Chang *Department of Pharmacy, Shanxi Medical University, Taiyuan, 030001, PR China. changruimiao@sxbqeh.com.cn.
Shumian Liu *Department of Pharmacy, Shanxi Medical University, Taiyuan, 030001, PR China.
Jingjing WangDepartment of Pharmacy, Shanxi Medical University, Taiyuan, 030001, PR China.
Huichun WangDepartment of Pharmacy, Shanxi Medical University, Taiyuan, 030001, PR China.
Shuai JiaDepartment of Pharmacy, Shanxi Medical University, Taiyuan, 030001, PR China.
Yuting YeDepartment of Pharmacy, Shanxi Medical University, Taiyuan, 030001, PR China.
Xinying QuDepartment of Pharmacy, Shanxi Medical University, Taiyuan, 030001, PR China.
Yong LiThird Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, 030001, PR China. liyong@sxbqeh.com.cn.
Ji ZhengThird Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, 030001, PR China. zhengji@sxbqeh.com.cn.
Xiaoxing FangFirst Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, 030001, PR China. jxgzsxmu@163.com.

Funding

China Postdoctoral Science Foundation 2023M732144Fundamental Research Program of Shanxi Province 202303021212315Shanxi Medical University Doctoral Initiation Fund Project BS201731the National Natural Science Foundation of China 32200323
6 · The paper itself

Abstract

We developed a highly sensitive electrochemical sensor based on zirconium-iron metal-organic frameworks (ZrFe-MOF) for the precise detection of ultra-low abundance miRNA-21. The construction of this sensor, through an innovative thermal alkaline activation strategy, exposed abundant binding sites on the surface of ZrFe-MOF, significantly improving aptamer (Apt) loading efficiency, thereby, achieving unprecedented sensitivity with a wide linear range (100 aM-10 nM, R² = 0.997) and a record-low detection limit of 19.33 aM - outperforming existing methods by 1-2 orders of magnitude. Besides, the biosensor successfully discriminates miRNA-21 expression profiles in breast cancer cell lines and breast adenocarcinoma (MDA-MB-231 vs. MCF-7 vs. MCF-10 A), showing high consistency with qPCR results. This work not only demonstrates a novel binding-site engineering strategy for nucleic acid detection but also presents a clinically viable platform for early cancer diagnosis with superior sensitivity, specificity, and reproducibility. This thermal-alkaline activation strategy could be extended to other bimetallic MOFs for multiplex miRNA detection, with future efforts targeting sensor miniaturization for point-of-care use. Current challenges include balancing the material's electron transfer efficiency with long-term storage stability and verifying the sensor's performance in large-scale clinical cohort samples.

Indexed as

Biosensing TechniquesElectrochemical TechniquesMetal-Organic FrameworksMicroRNAsZirconiumAptamers, NucleotideCell Line, TumorHumansIronLimit of DetectionTemperatureAptamers, NucleotideIronMetal-Organic FrameworksMicroRNAsMIRN21 microRNA, humanZirconiumAptamerElectrochemical biosensorMetal-organic frameworks (MOFs)MiRNA-21

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.